最新產(chǎn)品
- Thymocartin acetate 2025/9/12 21:43:30
- 主推FDA7001 2025/9/12 21:39:22
- Sabeluzole (Standard) 2025/9/12 21:43:06
- (Z)-SU14813 2025/9/12 21:42:42
- 推選FMA CJ01-AB00 2025/9/12 21:38:37
- Epelsiban besylate 2025/9/12 21:42:18
- Tecastemizole (Standard) 2025/9/12 21:41:54
- @市場(chǎng)推選EL40HU1 2025/9/12 21:37:51
- FK-739 free base 2025/9/12 21:41:30
- PH-064 (tetra(hydrochloride)) 2025/9/12 21:41:06
- Lexibulin (Standard) 2025/9/12 21:40:42
- Cobicistat (Standard) 2025/9/12 21:40:18
- AM580 (Standard) 2025/9/12 21:39:54
- Torkinib (Standard) 2025/9/12 21:39:29
- 推送FMA-CN22-AB00 2025/9/12 21:35:21
- GSK256066 (Standard) 2025/9/12 21:39:04
- NM107 (Standard) 2025/9/12 21:38:40
- 現(xiàn)貨FMACN10-PB10 2025/9/12 21:34:37
- HCV-796 analog 2025/9/12 21:38:16
- Daclatasvir (Standard) 2025/9/12 21:37:51
- 現(xiàn)貨FDA-7001 2025/9/12 21:33:44
- Daclatasvir dihydrochloride (Standard) 2025/9/12 21:37:27
- PF-573228 (Standard) 2025/9/12 21:37:03
- 主推Q60HB8NRD3 2025/9/12 21:32:58
- Carfilzomib (Standard) 2025/9/12 21:36:39
- Ixazomib (Standard) 2025/9/12 21:36:14
- Canagliflozin (Standard) 2025/9/12 21:35:50
- Dapagliflozin (Standard) 2025/9/12 21:35:25
- Dapagliflozin ((2S)-1,2-propanediol, hydrate) (Standard) 2025/9/12 21:35:01
- Pralatrexate (Standard) 2025/9/12 21:34:37